Bulevirtide for Chronic Hepatitis Delta

Gastroenterology. 2023 Dec;165(6):1574. doi: 10.1053/j.gastro.2023.05.007. Epub 2023 May 12.
No abstract available

MeSH terms

  • Antiviral Agents / adverse effects
  • Hepatitis B virus
  • Hepatitis Delta Virus / genetics
  • Hepatitis, Chronic*
  • Humans
  • Lipopeptides*

Substances

  • bulevirtide
  • Lipopeptides
  • Antiviral Agents